BamSEC and AlphaSense Join Forces
Learn More

Bio Green Med Solution, Inc. – Material Contracts

NASDAQ: BGMS    
Share price (8/28/26): $0.86    
Market cap (8/28/26): $5.696 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.39
from S-4/A 7 pages Dated Scheduled Wastes Management Services Agreement Between Future Nrg Sdn Bhd (Company No.814147-M) and Scheduled Wastes Management Services Agreement
12/34/56
EX-10.38
from S-4/A 16 pages Dated Scheduled Wastes Transporter Agreement Between Future Nrg Sdn Bhd (Company No.814147-M) and Scheduled Wastes Transporter Agreement
12/34/56
EX-10.37
from S-4/A 4 pages Amended and Restated Executive Officer and Director Services Agreement
12/34/56
EX-10.36
from S-4/A 4 pages Amended and Restated Executive Officer Services Agreement
12/34/56
EX-10.2
from 8-K 19 pages Registration Rights Agreement
12/34/56
EX-10.1
from 8-K 33 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 425 3 pages Exhibit F Form of Lock-Up Agreement
12/34/56
EX-10.1
from 8-K 3 pages Exhibit F Form of Lock-Up Agreement
12/34/56
EX-10.1
from 8-K 7 pages Warrant Exchange Agreement
12/34/56
EX-10.1
from 425 9 pages [***] Certain Information in This Document Has Been Excluded Pursuant to Regulation S-K, Item 601(b)(10). Such Excluded Information Is Not Material and Would Likely Cause Competitive Harm if Publicly Disclosed. Trademark License Agreement
12/34/56
EX-10.1
from 8-K 9 pages [***] Certain Information in This Document Has Been Excluded Pursuant to Regulation S-K, Item 601(b)(10). Such Excluded Information Is Not Material and Would Likely Cause Competitive Harm if Publicly Disclosed. Trademark License Agreement
12/34/56
EX-10.1
from 8-K 7 pages Warrant Exchange Agreement
12/34/56
EX-10.3
from 8-K 13 pages Amended and Restated Series C Common Stock Purchase Warrant Cyclacel Pharmaceuticals, Inc
12/34/56
EX-10.2
from 8-K 13 pages Amended and Restated Series B Common Stock Purchase Warrant Cyclacel Pharmaceuticals, Inc
12/34/56
EX-10.1
from 8-K 13 pages Amended and Restated Series a Common Stock Purchase Warrant Cyclacel Pharmaceuticals, Inc
12/34/56
EX-10.32
from S-4 4 pages Director Services Agreement
12/34/56
EX-10.31
from S-4 4 pages Director Services Agreement
12/34/56
EX-10.30
from S-4 4 pages Director Services Agreement
12/34/56
EX-10.29
from S-4 4 pages Executive Officer and Director Services Agreement
12/34/56
EX-10.28
from S-4 4 pages Executive Officer and Director Services Agreement
12/34/56